Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Cayman Chemical TRFRET asy BuFR AddItIve 200mg
Supplier: Cayman Chemical 600504200 MG
A quinolone antibiotic active against clinical isolates of S. pyogenes P aerUGinosa and P. acnes and clinical isolates of antibiotic-sensitive and -resistant S. aureus S. epidermidis and S. pneumoniae (MIC50s 0.00625-1.56 mg/L) inhibits S. aureus DNA gyrase and topoisomerase IV (IC50s 4.5 and 0.617 mg/L respectively) reduces insulin- or 5a-dihydroxy testosterone-induced triglyceride production and lipid droplet formation in primary hamster sebocytes at 30 UM decreases heat-killed C. acnes-induced increases in IL-6 and IL-8 production in HEKa primary human keratinocytes and IL-1B IL-6 IL-8 and TNF-a production in THP-1 monocytes at 30 UG/ml decreases skin lesion bacterial counts in a mouse model of burn infection caused by S. aureus
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?